feed,title,long_url,short_url
Investing,Ultragenyx stock rises after FDA grants breakthrough therapy status for Angelman syndrome drug,https://www.investing.com/news/stock-market-news/ultragenyx-stock-rises-after-fda-grants-breakthrough-therapy-status-for-angelman-syndrome-drug-93CH-4114580,
Investing,"Jefferies initiates Armada Hoffler at “buy,” targets 31% upside on NAV discount",https://www.investing.com/news/stock-market-news/jefferies-initiates-armada-hoffler-at-buy-targets-31-upside-on-nav-discount-4114572,
